Deutsche Bank’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-10,324
| Closed | -$21K | – | 4900 |
|
|
2019
Q4 | $21K | Buy |
+10,324
| New | +$21K | ﹤0.01% | 4127 |
|
|
2019
Q2 | – | Sell |
-10,212
| Closed | -$48K | – | 5148 |
|
|
2019
Q1 | $48K | Buy |
+10,212
| New | +$48K | ﹤0.01% | 4358 |
|
|
2018
Q4 | – | Sell |
-288
| Closed | -$2K | – | 5061 |
|
|
2018
Q3 | $2K | Sell |
288
-6,903
| -96% | -$47.9K | ﹤0.01% | 4789 |
|
|
2018
Q2 | $50K | Sell |
7,191
-28,786
| -80% | -$200K | ﹤0.01% | 4527 |
|
|
2018
Q1 | $301K | Buy |
35,977
+27,335
| +316% | +$229K | ﹤0.01% | 3888 |
|
|
2017
Q4 | $79K | Buy |
8,642
+5,078
| +142% | +$46.4K | ﹤0.01% | 4060 |
|
|
2017
Q3 | $41K | Sell |
3,564
-545
| -13% | -$6.27K | ﹤0.01% | 4122 |
|
|
2017
Q2 | $170K | Buy |
4,109
+3,152
| +329% | +$130K | ﹤0.01% | 3853 |
|
|
2017
Q1 | $46K | Buy |
957
+167
| +21% | +$8.03K | ﹤0.01% | 3983 |
|
|
2016
Q4 | $26K | Sell |
790
-530
| -40% | -$17.4K | ﹤0.01% | 4187 |
|
|
2016
Q3 | $53K | Sell |
1,320
-2,878
| -69% | -$116K | ﹤0.01% | 3942 |
|
|
2016
Q2 | $137K | Buy |
4,198
+3,801
| +957% | +$124K | ﹤0.01% | 3801 |
|
|
2016
Q1 | $24K | Sell |
397
-272
| -41% | -$16.4K | ﹤0.01% | 4286 |
|
|
2015
Q4 | $27K | Sell |
669
-2,579
| -79% | -$104K | ﹤0.01% | 4310 |
|
|
2015
Q3 | $177K | Sell |
3,248
-4,850
| -60% | -$264K | ﹤0.01% | 3700 |
|
|
2015
Q2 | $889K | Buy |
+8,098
| New | +$889K | ﹤0.01% | 2992 |
|
|
2015
Q1 | – | Sell |
-608
| Closed | -$34K | – | 5465 |
|
|
2014
Q4 | $34K | Buy |
608
+45
| +8% | +$2.52K | ﹤0.01% | 4841 |
|
|
2014
Q3 | $40K | Buy |
563
+533
| +1,777% | +$37.9K | ﹤0.01% | 4529 |
|
|
2014
Q2 | $4K | Sell |
30
-138
| -82% | -$18.4K | ﹤0.01% | 5053 |
|
|
2014
Q1 | $24K | Buy |
+168
| New | +$24K | ﹤0.01% | 4715 |
|